Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report

  title={Management of Helicobacter pylori infection—the Maastricht IV/ Florence Consensus Report},
  author={Peter Malfertheiner and Francis M{\'e}graud and C O'Morain and John J. Atherton and Anthony T. R. Axon and Franco Bazzoli and Gian Franco Gensini and Javier P. Gisbert and David Yates Graham and Theodore Rokkas and Emad M El-Omar and Ernst J. Kuipers},
  pages={646 - 664}
Management of Helicobacter pylori infection is evolving and in this 4th edition of the Maastricht consensus report aspects related to the clinical role of H pylori were looked at again in 2010. [] Key Method In the 4th Maastricht/Florence Consensus Conference 44 experts from 24 countries took active part and examined key clinical aspects in three subdivided workshops: (1) Indications and contraindications for diagnosis and treatment, focusing on dyspepsia, non-steroidal anti-inflammatory drugs or aspirin use…

Management of Helicobacter pylori infection—the Maastricht V/Florence Consensus Report

This fifth edition of the Maastricht Consensus Report describes how experts from 24 countries examined new data related to H. pylori infection in the various clinical scenarios and provided recommendations on the basis of the best available evidence and relevance.

Guidelines for the management of Helicobacter pylori infection in Italy: The III Working Group Consensus Report 2015.

  • R. ZagariM. Romano M. Caselli
  • Medicine
    Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver
  • 2015

Helicobacter pylori management in ASEAN: The Bangkok consensus report

Helicobacter pylori (H. pylori) infection remains to be the major cause of important upper gastrointestinal diseases such as chronic gastritis, peptic ulcer, gastric adenocarcinoma, and

Management of Helicobacter Pylori Infection and Effectiveness Rates in Daily Clinical Practice in Spain: 2010–2019

Despite the use of quadruple therapies and optimized treatments, the effectiveness of H. pylori management in daily clinical practice is far from the target of 90%.

Update in Pathophysiology and Management of Helicobacter pylori in Children

Its role in some hematologic conditions has been fully validated and included in the current guidelines and further studies are still needed to evaluate the role of Helicobacter pylori in other diseases.

Letter to the editor: Helicobacter pylori eradication – the proof is not in the symptoms

The authors recommend that successful eradication of Helicobacter pylori after ‘test and treat’ should only be confirmed in patients with an increased risk of gastric cancer, and advocate testing for eradication success in all patients.

[Croatian guidelines for diagnostics and treatments of Helicobacter pylori infection].

The working expert group of gastroenterologists was formed and gathered on Consesus Conference in December 2012 in Zagreb, to arrive to current guidelines for the clinical management of Helicobacter pylori infection in Croatia.

Helicobacter pylori eradication in dyspepsia: New evidence for symptomatic benefit.




Current concepts in the management of Helicobacter pylori infection: the Maastricht III Consensus Report

H pylori eradication is less effective than proton pump inhibitor (PPI) treatment in preventing ulcer recurrence in long term NSAID users and a test and treat strategy using a non-invasive test is recommended in adult patients with persistent dyspepsia under the age of 45.

Current concepts in the management of Helicobacter pylori infection—The Maastricht 2‐2000 Consensus Report

The European Helicobacter Pylori Study Group organized a meeting of specialists and experts from around the world, representatives from National Gastroenterology Societies and general practitioners from Europe to establish updated guidelines on the current management of Helicobacteria pylori infection.

Current European concepts in the management of Helicobacter pylori infection--the Maastricht Consensus Report. The European Helicobacter Pylori Study Group (EHPSG).

There was consensus that treatment regimens should be simple, well tolerated and achieve an eradication rate of over 80% on an intention to treat basis.

The response of Asian patients with functional dyspepsia to eradication of Helicobacter pylori infection

It is suggested that patients with FD in Asia would benefit from treatment for H. pylori infection with as much as a 13-fold increased chance of symptom resolution following its eradication.

Review article: Helicobacter pylori and gastro‐oesophageal reflux disease—clinical implications and management

  • O’connor
  • Medicine
    Alimentary pharmacology & therapeutics
  • 1999
The aim of this review was to critically assess the relationship between H. pylori and GERD and its potential implications for the management of GERD.

Guidelines for treatment of Helicobacter pylori in the East and West

The reasons for treatment failure are reported, the overview of new treatment options as alternatives to the current treatment regimens are given, and the strategy for the future is considered.

Is Helicobacter pylori infection a necessary condition for noncardia gastric cancer?

The H. pylori-gastric cancer relation may be much stronger than previously thought, and H.pylori infection may even be a (close to) necessary condition for development of noncardia gastric cancer.

Helicobacter pylori and gastroduodenal ulcer disease.

This guideline enables the structured, evidence-based diagnosis and treatment of H. pylori infection and associated conditions, as well as of gastroduodenal ulcer disease.

13C-Urea Breath Test for Diagnosis of Helicobacter pylori Infection in the Elderly

The aims of the study were to characterize geriatric patients according to referral patterns and results of the 13C-urea breath test and to investigate the results of treatment combinations for H. pylori eradiction.

Helicobacters and Extragastric Diseases

This review attempts to highlight the main reported associations of H. pylori with extragastric manifestations during the last year in the field of idiopathic thrombocytopenic purpura (ITP) and sideropenic anemia.